Contact us
Do you have questions about our products or services? We’re here to help. Contact a Roche representative in your region.
Make the right choice for you when it comes to coagulation monitoring.
It is important to keep your blood’s clotting time within the range prescribed by your doctor. You may need to take your anticoagulant for a few weeks, months or even for the rest of your life. But no matter how long, your levels need to be regularly measured and that’s where INR self-testing is a great benefit.
Have the peace of mind that you know your INR value when needed, home or away. Self-monitoring only requires a drop of blood and results are available in about a minute.1 Results can either be reported to your doctor or nurse who will adjust your vitamin K antagonist dose for you, or you can learn how to adjust the dose yourself.
Say yes to more me time. Discover the benefits of INR self-testing.
More freedom
Test your INR anywhere and anytime with immediate results that are comparable to those you would get from the lab2,3
INR self-testing can lead to fewer visits to the laboratory, no waiting for test results, and fewer calls or visits to your doctor for dose adjustment decisions4-6
More control
Gain better control of your anticoagulation therapy. Compared to having your INR values tested in the laboratory or anticoagulation clinic, INR self-testing can lead to:
- More time in your therapeutic range7-9
- Fewer incidents of very high or low INR values10
Better care
Studies show that INR self-testing can lead to:
- Improved health and quality of life6-8,11,12,14,15
- Better treatment satisfaction13-15
Explore articles from our community
Abbreviations
INR: International Normalized Ratio
References
- Roche Diagnostics Ltd. CoaguCheck XS PST Test package insert; V7.1, 2021
- Plesch et al. (2009). Int J Lab Hematol 31, 20–25
- Ryan et al. (2010). Int J Lab Hematol 32, e26–33
- Grunau et al. (2011). Can Fam Physician 57, e292-e298
- Bloomfield et al. (2011). Ann Intern Med 154, 472–482
- Sharma et al. (2015). Health Technol Assess 19, 1–172
- Garcia-Alamino et al. (2010). Cochrane Database Syst Rev 4, CD003839
- Soliman Hamad et al. (2009). Eur J Cardiothorac Surg 35, 265–269
- Siebenhofer et al. (2007). Thromb Haemost 97, 408–416
- Dignan et al. (2013). Int J Cardiol 168, 5378–5384
- Heneghan et al..(2012). Lancet 379, 322–334
- Christensen et al..(2016). Ann Thorac Surg 101, 1494–1499
- Siebenhofer et al. (2012). Thromb Res 130, e60–e66
- Tamayo Aguirre et al. (2016). BMC Cardiovasc Disord 16, 180
- Verret et al. (2012). Pharmacotherapy 32, 871–879